Literature DB >> 21879377

Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients.

Adel Mohammadzadeh1, Ali Akbar Pourfathollah, Mohammad Taher Tahoori, Saeed Daneshmandi, Ladan Langroudi, Masoumeh Akhlaghi.   

Abstract

Apoptosis signals are essential for establishing homeostasis and adequate immune response. Dysregulation of apoptosis-related genes in the immune system, which could be due to gene polymorphisms, conduct to autoimmune diseases including rheumatoid arthritis. In the current study, the apoptosis-related gene Fas_-670A>G, FasL_844C>T, and FasLIVS2nt_124A>G polymorphisms were genotyped in 120 Iranian patients with rheumatoid arthritis (RA) and 112 unrelated healthy controls using PCR-RFLP method. Among the 120 RA patients being heterozygous in the promoter region of Fas_-670A/G (OR 1.42,CI 0.92-1.52, P = 0.18) and FasL_-844C/T (OR 1.42, CI 0.92-1.52, P = 0.18) and homozygous in the minor allele for FasLIVS2nt_124G/G (OR 1.43, CI 0.76-1.81, P = 0.7), the frequency of these polymorphisms is higher in the cases than in controls and the elevated risk of RA were observed when the patient compared with controls, although this is not statistically significant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879377     DOI: 10.1007/s00296-011-2065-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium.

Authors:  H Asahara; T Hasunuma; T Kobata; H Inoue; U Muller-Ladner; S Gay; T Sumida; K Nishioka
Journal:  J Rheumatol       Date:  1997-03       Impact factor: 4.666

2.  Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL.

Authors:  Seon Hee Kim; Sunyoung Kim; Thomas J Oligino; Paul D Robbins
Journal:  Mol Ther       Date:  2002-11       Impact factor: 11.454

3.  Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.

Authors:  Q R Huang; D Morris; N Manolios
Journal:  Mol Immunol       Date:  1997-06       Impact factor: 4.407

4.  Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.

Authors:  Anca Irinel Catrina; Christina Trollmo; Erik af Klint; Marianne Engstrom; Jon Lampa; Ylva Hermansson; Lars Klareskog; Ann Kristin Ulfgren
Journal:  Arthritis Rheum       Date:  2005-01

Review 5.  Apoptosis as a therapeutic tool in rheumatoid arthritis.

Authors:  Richard M Pope
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

6.  A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients.

Authors:  Jianming Wu; Christine Metz; Xiulong Xu; Riichiro Abe; Andrew W Gibson; Jeffrey C Edberg; Jennifer Cooke; Fenglong Xie; Glinda S Cooper; Robert P Kimberly
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

7.  FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.

Authors:  Jörg Schedel; Renate E Gay; Peter Kuenzler; Christian Seemayer; Beat Simmen; Beat A Michel; Steffen Gay
Journal:  Arthritis Rheum       Date:  2002-06

8.  A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

Authors:  Satomi Kanemitsu; Kenji Ihara; Ahmed Saifddin; Takeshi Otsuka; Tsutomu Takeuchi; Jun Nagayama; Michihiko Kuwano; Toshiro Hara
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

9.  Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

Authors:  Kathryn Sibley; Sara Rollinson; James M Allan; Alexandra G Smith; Graham R Law; Philippa L Roddam; Christine F Skibola; Martyn T Smith; Gareth J Morgan
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

10.  Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.

Authors:  H Das; T Koizumi; T Sugimoto; S Chakraborty; T Ichimura; K Hasegawa; R Nishimura
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  8 in total

1.  Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK/β-catenin pathway.

Authors:  Cheng Qian; Li Qian; Yizhi Yu; Huazhang An; Zhenhong Guo; Yanmei Han; Yongjian Chen; Yi Bai; Qingqing Wang; Xuetao Cao
Journal:  J Biol Chem       Date:  2013-08-13       Impact factor: 5.157

2.  Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis.

Authors:  Melek Sezgin; İbrahim Ömer Barlas; Seyfi Yıldır; Gözde Türköz; Handan Çamdeviren Ankaralı; Günşah Şahin; Mehmet Emin Erdal
Journal:  Rheumatol Int       Date:  2013-02-08       Impact factor: 2.631

3.  Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.

Authors:  Aiping Zhu; Mingjie Wang; Guoxin Zhou; Hui Zhang; Ruiping Liu; Yong Wang
Journal:  Rheumatol Int       Date:  2016-02-23       Impact factor: 2.631

4.  Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.

Authors:  Seyfi Yıldır; Melek Sezgin; Ibrahim Ömer Barlas; Gözde Türköz; Handan Çamdeviren Ankaralı; Günşah Şahin; Mehmet Emin Erdal
Journal:  Rheumatol Int       Date:  2013-06-09       Impact factor: 2.631

Review 5.  Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Yasusei Kudo; Naozumi Ishimaru
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

6.  Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.

Authors:  Donghua Huang; Jinrong Xiao; Xiangyu Deng; Kaige Ma; Hang Liang; Deyao Shi; Fashuai Wu; Zengwu Shao
Journal:  BMC Musculoskelet Disord       Date:  2018-05-07       Impact factor: 2.362

7.  Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.

Authors:  Hongwei Yan; Yuxiao Hong; Yunfei Cai
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

8.  FasL (rs763110) gene polymorphism is not associated with susceptibility to rheumatoid arthritis in Croatian population.

Authors:  Marinko Artuković; Marina Ikić Matijašević; Antonio Markotić; Alan Šućur; Danka Grčević; Nataša Kovačić; Darja Flegar; Asja Stipić Marković; Dino Šisl; Irena Artuković; Tomislav Kelava
Journal:  Croat Med J       Date:  2020-12-31       Impact factor: 1.351

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.